PMC:7306567 / 33209-33580
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T165 | 91-94 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
| T166 | 155-158 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
| T167 | 195-198 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
| T168 | 222-225 | Disease | denotes | BMS | http://purl.obolibrary.org/obo/MONDO_0006687 |
| T169 | 260-263 | Disease | denotes | BMS | http://purl.obolibrary.org/obo/MONDO_0006687 |
| T170 | 273-276 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
| T171 | 300-302 | Disease | denotes | he | http://purl.obolibrary.org/obo/MONDO_0017319 |
| T172 | 332-335 | Disease | denotes | BMS | http://purl.obolibrary.org/obo/MONDO_0006687 |
| T173 | 345-348 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T218 | 110-113 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T247 | 0-371 | Sentence | denotes | BJA Rijnders was the investigator for studies supported by Gilead Sciences, Janssen-Cilag, MSD, Pfizer, ViiV; has received research grants from Gilead and MSD; was an invited speaker for Gilead, MSD, Pfizer, Jansen-Cilag, BMS; and an advisory board member for BMS, Abbvie, MSD, Gilead, Jansen-Cilag; he received travel support from BMS, Abbvie, MSD, Gilead, Jansen-Cilag. |